Cory S - Search Results

1

Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim.

Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM. Bouillet P, et al. Among authors: cory s. Dev Cell. 2001 Nov;1(5):645-53. doi: 10.1016/s1534-5807(01)00083-1. Dev Cell. 2001. PMID: 11709185

2

Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.

Tuzlak S, Haschka MD, Mokina AM, Rülicke T, Cory S, Labi V, Villunger A. Tuzlak S, et al. Among authors: cory s. FEBS J. 2018 Apr;285(8):1403-1418. doi: 10.1111/febs.14426. Epub 2018 Mar 24. FEBS J. 2018. PMID: 29498802 Free PMC article.

3

Mnt modulates Myc-driven lymphomagenesis.

Campbell KJ, Vandenberg CJ, Anstee NS, Hurlin PJ, Cory S. Campbell KJ, et al. Among authors: cory s. Cell Death Differ. 2017 Dec;24(12):2117-2126. doi: 10.1038/cdd.2017.131. Epub 2017 Aug 11. Cell Death Differ. 2017. PMID: 28800127 Free PMC article.

4

Targeting BCL-2-like Proteins to Kill Cancer Cells.

Cory S, Roberts AW, Colman PM, Adams JM. Cory S, et al. Trends Cancer. 2016 Aug;2(8):443-460. doi: 10.1016/j.trecan.2016.07.001. Epub 2016 Jul 30. Trends Cancer. 2016. PMID: 28741496 Review.

5

Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice.

Anstee NS, Vandenberg CJ, Campbell KJ, Hughes PD, O'Reilly LA, Cory S. Anstee NS, et al. Among authors: cory s. Cell Death Differ. 2017 Mar;24(3):397-408. doi: 10.1038/cdd.2016.125. Epub 2016 Nov 4. Cell Death Differ. 2017. PMID: 27813531 Free PMC article.

6

Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice.

Bilardi RA, Anstee NS, Glaser SP, Robati M, Vandenberg CJ, Cory S. Bilardi RA, et al. Among authors: cory s. Cell Death Dis. 2016 Sep 1;7(9):e2351. doi: 10.1038/cddis.2016.258. Cell Death Dis. 2016. PMID: 27584789 Free PMC article.

7

Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained.

Vandenberg CJ, Waring P, Strasser A, Cory S. Vandenberg CJ, et al. Among authors: cory s. Blood. 2014 Aug 14;124(7):1099-109. doi: 10.1182/blood-2014-04-570770. Epub 2014 Jul 1. Blood. 2014. PMID: 24986687 Free PMC article.

8

ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia.

Vandenberg CJ, Cory S. Vandenberg CJ, et al. Among authors: cory s. Blood. 2013 Mar 21;121(12):2285-8. doi: 10.1182/blood-2013-01-475855. Epub 2013 Jan 22. Blood. 2013. PMID: 23341542 Free PMC article.

9

Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim.

Happo L, Cragg MS, Phipson B, Haga JM, Jansen ES, Herold MJ, Dewson G, Michalak EM, Vandenberg CJ, Smyth GK, Strasser A, Cory S, Scott CL. Happo L, et al. Among authors: cory s. Blood. 2010 Dec 9;116(24):5256-67. doi: 10.1182/blood-2010-04-280818. Epub 2010 Sep 9. Blood. 2010. PMID: 20829369 Free PMC article.

10

Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.

Campbell KJ, Bath ML, Turner ML, Vandenberg CJ, Bouillet P, Metcalf D, Scott CL, Cory S. Campbell KJ, et al. Among authors: cory s. Blood. 2010 Oct 28;116(17):3197-207. doi: 10.1182/blood-2010-04-281071. Epub 2010 Jul 14. Blood. 2010. PMID: 20631380 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results